Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney diseaseMiki Imazu, Masafumi Kitakaze, Hiroyuki Takahama et al.|American Journal of Physiology-Heart and Circulatory Physiology|2014Cited by 44
Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failureMiki Imazu, Masafumi Kitakaze, Hiroki Fukuda et al.|Scientific Reports|2020Cited by 27
Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failureMiki Imazu, Masafumi Kitakaze, Hiroyuki Takahama et al.|Hypertension Research|2016Cited by 15
Non-linear Equation using Plasma Brain Natriuretic Peptide Levels to Predict Cardiovascular Outcomes in Patients with Heart FailureHiroki Fukuda, Masafumi Kitakaze, Hideaki Suwa et al.|Scientific Reports|2016Cited by 12
A Pathophysiological Role of Plasma Indoxyl Sulfate in Patients with Heart FailureMiki Imazu, Masafumi Kitakaze, Hiroyuki Takahama et al.|International journal of gerontology|2017Cited by 11